Brief: Invivyd Announces Completion Of Enrollment In Upsized Declaration Clinical Trial
01/06/2026 12:25
BRIEF-Invivyd Announces Completion Of Enrollment In Upsized Declaration Clinical Trial June 1 (Reuters) - Invivyd Inc IVVD.O:
INVIVYD ANNOUNCES COMPLETION OF ENROLLMENT IN UPSIZED DECLARATION CLINICAL TRIAL, A PHASE 3 PIVOTAL STUDY OF VYD2311, AN INVESTIGATIONAL ANTIBODY TO PREVENT COVID
Source text: ID:nGNX2Ffx9v
Further company coverage: IVVD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invivyd
See all newsBrief: Invivyd Announces Positive Topline Results From Liberty Phase 3 Study Demonstrating Vyd2311 Safety And Tolerability Superior To Mrna-Based Covid-19 Vaccine Announces Regulatory Submission Plans For Vyd2311
Invivyd, Inc. reports results for the quarter ended June 30 - Earnings Summary
Invivyd Q2 loss per share comes wider than expected on higher costs
Brief: Invivyd Q2 EPS USD -0.14
Invivyd, Inc. expected to post a loss of 11 cents a share - Earnings Preview